Company Advanced Cell Technology, Inc. OTC Bulletin Board
Equities
ACTC
US00752K1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
John Heffernan
PRN | Corporate Officer/Principal | - | 15-02-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 51 | - | |
Masaaki Hirano
BRD | Director/Board Member | 57 | - |
Toru Yoshimitsu
BRD | Director/Board Member | 61 | - |
President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,300,462 | 38,904,811 ( 91.97 %) | 0 | 91.97 % |
Company contact information
Astellas Institute for Regenerative Medicine
33 Locke Drive
01752, Marlborough
+508-756-1212
https://www.ocata.com![address Advanced Cell Technology, Inc.(ACTC)](https://cdn.zonebourse.com/static/address/3705051.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- Stock
- ACTC Stock
- Company Advanced Cell Technology, Inc.